<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39424219</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5867</ISSN><JournalIssue CitedMedium="Internet"><Volume>212</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Steroids</Title><ISOAbbreviation>Steroids</ISOAbbreviation></Journal><ArticleTitle>Invalidating betulinic acid as a potential inhibitor against the main protease of SARS-CoV-2 via combined approaches.</ArticleTitle><Pagination><StartPage>109522</StartPage><MedlinePgn>109522</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.steroids.2024.109522</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0039-128X(24)00160-0</ELocationID><Abstract><AbstractText>In contrast to an earlier study reporting that betulinic acid is an inhibitor of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro), we demonstrated that beutilinic acid is not a potential Mpro inhibitor via combined approaches, including the fluorescence resonance energy transfer (FRET) assay, the fluorescence polarization (FP) assay, and the protease biosensor cleavage assay. Our results suggest that the addition of detergent to the assay buffers is essential for evaluating natural products as Mpro inhibitors. It is necessary to conduct comprehensive testing of Mpro inhibition via combined approaches for antiviral development.</AbstractText><CopyrightInformation>Copyright Â© 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Jiankai</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu 241002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu 241002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu 241002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu 241002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu 241002, China. Electronic address: zhangchao@wnmc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yunyu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu 241002, China. Electronic address: chenyunyu1984@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Steroids</MedlineTA><NlmUniqueID>0404536</NlmUniqueID><ISSNLinking>0039-128X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Betulinic acid</Keyword><Keyword MajorTopicYN="N">Colloidal aggregation effect</Keyword><Keyword MajorTopicYN="N">Fluorescence polarization</Keyword><Keyword MajorTopicYN="N">Main protease inhibitor</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39424219</ArticleId><ArticleId IdType="doi">10.1016/j.steroids.2024.109522</ArticleId><ArticleId IdType="pii">S0039-128X(24)00160-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle>